Explorer les evidences

7 patientsOnly 7 out of 46 patients (15.2%) had the total treatment time within 90 days of symptom onset.

Nigeriacancer du seinpublié 2025BMC cancerPubMeddocument de 11 observations

76,7 %76.7% of respondents were Christians in a study of breast cancer patients at University College Hospital, Ibadan, Nigeria.

Nigeriacancer du seinobservé 2018publié 2019Journal of global oncologyPubMeddocument de 9 observations

25 %Breast cancer constitutes 25% of all cancer cases diagnosed in Kano State, Nigeria.

Nigeriacancer du seinpublié 2025Breast cancer (Tokyo, Japan)PubMeddocument de 8 observations

44 %Breast cancer has a 5-year survival of 44% in Nigeria.

Nigeriacancer du seinpublié 2026JCO global oncologyPubMeddocument de 3 observations

51,6 %51.6% of respondents had tertiary education in a study of breast cancer patients at University College Hospital, Ibadan, Nigeria.

Nigeriacancer du seinobservé 2018publié 2019Journal of global oncologyPubMeddocument de 9 observations

20,61 scoreThe mean breast cancer knowledge score improved from 20.61 ± 13.4 prior to training to 55.93 ± 10.86 following peer training, with p < 0.0001.

Nigeriacancer du seinpublié 2021BMC women's healthPubMeddocument de 4 observations

1,22 odds_ratioA novel breast cancer risk variant in region 5q11.2 has an odds ratio of 1.22 with a 95% confidence interval of 1.09–1.36 and a p-value of 0.00053 in women of African ancestry.

Nigeriacancer du seinpublié 2013Carcinogenesiseurope_pmcdocument de 4 observations

0,028 p_valueBreast cancer risk reduced as socio-economic index increased with p for trend=0.028.

Nigeriacancer du seinpublié 2022The Pan African medical journalPubMeddocument de 5 observations

Breast cancer is the most common cancer and the second leading cause of death among women in Nigeria.

Nigeriacancer du seinpublié 2026JCO global oncologyPubMeddocument de 3 observations

67,6 %67.6% of the respondents were breast cancer patients.

Nigeriacancer du seinpublié 2026BMC women's healthPubMeddocument de 6 observations

862 patientsHealth records of 862 patients with breast cancer were analysed across six tertiary care institutions in Ghana, Kenya, and Nigeria.

Ghana · Kenya · Nigeriacancer du seinobservé 2014 to 2017publié 2021BMJ openPubMeddocument de 13 observations

0,965 rA positive significant correlation was observed between total cholesterol and LDL (r = 0.965, p < 0.0001) in the breast cancer patients.

Nigeriacancer du seinpublié 2025Breast cancer (Tokyo, Japan)PubMeddocument de 8 observations

25 %The incidence of breast cancer was highest in patients aged 41–50 years (25%).

Nigeriacancer du seinpublié 2025Breast cancer (Tokyo, Japan)PubMeddocument de 8 observations

12,6 %In the MEND case-control study, 12.6% of Nigerian breast cancer cases were HER2-enriched.

Nigeriacancer du sein · HER2-enrichedpublié 2026Breast cancer research and treatmentPubMeddocument de 10 observations

41,49 %41.49% of the respondents had poor breast self-examination practice.

Nigeriacancer du seinpublié 2023BMC women's healthPubMeddocument de 12 observations

68,5 %Receipt of adjuvant radiotherapy after systemic chemotherapy was associated with improved survival in patients with locally advanced breast cancer in Nigeria between January 2010 and December 2018: 68.5% (95% CI: 46.3 to 86) versus 51% (95% CI: 38.6 to 61.9).

Nigeriacancer du seinobservé 2010–2018publié 2021International journal of cancerPubMeddocument de 12 observations

19 %Nineteen percent (n = 42/224) had not heard of breast cancer before diagnosis.

Nigeriacancer du seinpublié 2026Psycho-oncologyPubMeddocument de 11 observations

74,6 %Most participants (74.6%) presented with advanced breast cancers (stage 3 and 4).

Nigeriacancer du seinpublié 2026BMC cancerPubMeddocument de 8 observations

20 %20% of the tumors were progesterone receptor-positive.

Nigeriacancer du seinpublié 2009Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument de 12 observationsDOI 10.1200/jco.2008.19.6873

1,9 score_unitsThe genetic counseling module showed a mean knowledge score change of 1.9 (95% CI, 1.3 to 2.5) among Nigerian health care providers.

Nigeriacancer du seinpublié 2026JCO global oncologyPubMeddocument de 5 observations

0,419 rA positive significant correlation was observed between LDL and triglycerides (r = 0.419, p = 0.002) in the breast cancer patients.

Nigeriacancer du seinpublié 2025Breast cancer (Tokyo, Japan)PubMeddocument de 8 observations

62 %For postmenopausal women, each standard deviation increase in cumulative lifetime endogenous estrogen exposure (CLEEE) was associated with 62% higher breast cancer odds in multivariable models.

Nigeriacancer du seinpublié 2026Breast cancer research and treatmentPubMeddocument de 10 observations

24 %24% of the tumors were estrogen receptor (ER)-positive.

Nigeriacancer du seinpublié 2009Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument de 12 observationsDOI 10.1200/jco.2008.19.6873

7 %EGFR amplification was found in 7% of breast cancer patients in the study.

Nigeriacancer du seinpublié 2026Cancer geneticsPubMeddocument de 4 observations

10,9 %In the MEND case-control study, 10.9% of Nigerian breast cancer cases were luminal B.

Nigeriacancer du sein · luminal Bpublié 2026Breast cancer research and treatmentPubMeddocument de 10 observations